Robert J. Marder

1.5k total citations
38 papers, 1.3k citations indexed

About

Robert J. Marder is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Robert J. Marder has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 11 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Immunology. Recurrent topics in Robert J. Marder's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Glycosylation and Glycoproteins Research (5 papers). Robert J. Marder is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Glycosylation and Glycoproteins Research (5 papers). Robert J. Marder collaborates with scholars based in United States. Robert J. Marder's co-authors include Jane N. Winter, Alan L. Epstein, H Gewurz, Daina Variakojis, Frank R. Schmid, Clive R. Taylor, Robin Goldman-Leikin, Steven T. Rosen, Jōhn W. Parker and Fengming Chen and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer.

In The Last Decade

Robert J. Marder

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Marder United States 16 431 339 332 298 223 38 1.3k
Bruce A. Robbins United States 17 303 0.7× 147 0.4× 271 0.8× 287 1.0× 192 0.9× 26 963
Paul E. Hurtubise United States 22 227 0.5× 165 0.5× 335 1.0× 407 1.4× 200 0.9× 60 1.4k
P Souteyrand France 25 585 1.4× 157 0.5× 862 2.6× 539 1.8× 410 1.8× 92 2.1k
Haruki Wakasa Japan 20 582 1.4× 79 0.2× 361 1.1× 392 1.3× 188 0.8× 104 1.4k
P M Lydyard United Kingdom 20 131 0.3× 231 0.7× 181 0.5× 1000 3.4× 300 1.3× 49 1.6k
J Gordon United Kingdom 24 185 0.4× 368 1.1× 120 0.4× 596 2.0× 326 1.5× 47 1.4k
Nathalie Balandraud France 25 246 0.6× 365 1.1× 329 1.0× 536 1.8× 318 1.4× 56 1.8k
Paul A. Chervenick United States 21 157 0.4× 182 0.5× 466 1.4× 493 1.7× 254 1.1× 40 1.7k
Kuniyuki Oka Japan 24 332 0.8× 144 0.4× 629 1.9× 264 0.9× 413 1.9× 101 1.8k
Maryvonne Dueymes France 21 249 0.6× 230 0.7× 82 0.2× 592 2.0× 288 1.3× 60 1.5k

Countries citing papers authored by Robert J. Marder

Since Specialization
Citations

This map shows the geographic impact of Robert J. Marder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Marder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Marder more than expected).

Fields of papers citing papers by Robert J. Marder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Marder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Marder. The network helps show where Robert J. Marder may publish in the future.

Co-authorship network of co-authors of Robert J. Marder

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Marder. A scholar is included among the top collaborators of Robert J. Marder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Marder. Robert J. Marder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oleske, Denise M., et al.. (1998). Cesarean and VBAC Delivery Rates in Medicaid Managed Care, Medicaid Fee‐for‐Service, and Private Managed Care. Birth. 25(2). 125–127. 6 indexed citations
2.
Hassaballa, Hesham A., et al.. (1998). Enhancing Clinical Pathway Placement. Quality Management in Health Care. 7(1). 13–17. 4 indexed citations
3.
Marder, Robert J.. (1991). Measuring the quality of care for the cancer patient. Cancer. 67(S6). 1753–1758. 4 indexed citations
4.
Koch, Alisa E., et al.. (1991). Monoclonal antibodies detect monocyte/macrophage activation and differentiation antigens and identify functionally distinct subpopulations of human rheumatoid synovial tissue macrophages.. PubMed. 138(1). 165–73. 41 indexed citations
5.
Koch, Alisa E., James C. Burrows, Robert J. Marder, Peter H. Domer, & S. Joseph Leibovich. (1990). Reactivity of Human Tissues with Monoclonal Antibodies to Myeloid Activation and Differentiation Antigens. Pathobiology. 58(5). 241–248. 8 indexed citations
6.
Marder, Robert J.. (1990). Relationship of Clinical Indicators and Practice Guidelines. QRB - Quality Review Bulletin. 16(2). 60–60. 12 indexed citations
7.
Marder, Robert J.. (1989). Joint commission plans for clinical indicator development for oncology. Cancer. 64(S1). 310–313. 4 indexed citations
8.
9.
Marder, Robert J., et al.. (1988). Heterogeneity of Phenotypic Expression in Normal and Neoplastic B-Cell Proliferations Detected by Monoclonal Antibodies LN-1 and DLC-48. American Journal of Clinical Pathology. 90(2). 149–155. 3 indexed citations
10.
Variakojis, Daina, et al.. (1988). Primary histiocytosis X of the parieto-occipital lobe. Human Pathology. 19(5). 611–614. 24 indexed citations
11.
Gould, Victor E., Helen R. Salwen, C.v. Herst, et al.. (1987). Establishment and characterization of a neuroendocrine skin carcinoma cell line.. PubMed. 56(3). 302–12. 85 indexed citations
12.
Herman, C. J., et al.. (1987). Recent progress in clinical quantitative cytology.. PubMed. 111(6). 505–12. 20 indexed citations
13.
Goldman-Leikin, Robin, C.v. Herst, M.S. Kies, et al.. (1987). Human T-cell lymphotropic virus type I-associated adult T-cell leukemia/lymphoma in an atypical host.. PubMed. 111(11). 1054–6. 4 indexed citations
14.
Winter, Jane N., Robert J. Marder, Walter W. Hauck, et al.. (1986). Phenotypic Analysis in Diffuse, Large Cell Lymphoma: Clinical and Histologic Associations. American Journal of Clinical Pathology. 85(4). 425–432. 4 indexed citations
15.
Marder, Robert J., et al.. (1986). Phase II trial of tamoxifen in chronic lymphocytic leukemia.. PubMed. 70(11). 1343–4. 1 indexed citations
16.
Simpson, Joe Leigh, Lora D. Baum, Robert J. Marder, et al.. (1986). Maternal serum α-fetoprotein screening: Low and high values for detection of genetic abnormalities. American Journal of Obstetrics and Gynecology. 155(3). 593–597. 22 indexed citations
17.
Wolff, Peregrine L., Jerome M. Garden, Robert J. Marder, Daniel W. Rosenberg, & John P. Sundberg. (1986). Pemphigus vulgaris in a pigtail macaque. Journal of the American Veterinary Medical Association. 189(9). 1220–1221. 10 indexed citations
18.
Braun, Donald P., et al.. (1981). Chemiluminescence in peripheral blood mononuclear cells of solid tumor cancer patients. Cancer Immunology Immunotherapy. 12(1). 13 indexed citations
19.
Marder, Robert J., Jeffrey M. Becker, & Fred Naider. (1977). Peptide transport in yeast: utilization of leucine- and lysine-containing peptides by Saccharomyces cerevisiae. Journal of Bacteriology. 131(3). 906–916. 31 indexed citations
20.
Marder, Robert J., et al.. (1976). C1q deficiency associated with urticarial-like lesions and cutaneous vasculitis. The American Journal of Medicine. 61(4). 560–565. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce A. Robbins Breakdown of academic impact, for papers by Paul E. Hurtubise Breakdown of academic impact, for papers by P Souteyrand Breakdown of academic impact, for papers by Haruki Wakasa Breakdown of academic impact, for papers by P M Lydyard Breakdown of academic impact, for papers by J Gordon Breakdown of academic impact, for papers by Nathalie Balandraud Breakdown of academic impact, for papers by Paul A. Chervenick Breakdown of academic impact, for papers by Kuniyuki Oka Breakdown of academic impact, for papers by Maryvonne Dueymes
Rankless by CCL
2026